Pure Global AI
Cyprus flag

Cyprus medical device registration timeline

Source-linked clocks

Αρμόδια Αρχή Ιατροτεχνολογικού Εξοπλισμού (CYMDA), Medical Services and Public Health Services, Ministry of Health (Ministry of Health) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) — EU MDR classification system.

1 pathways1 of 1 clocks verifiedvalidity 5 years (CE certificate)MDSAP not acceptedreviewed 2026-09-16eur-lex.europa.eu
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Self-declaration (no notified body))
MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so neither the CYMDA nor a notified body reviews the file and there is no review clock
0 days6-9 monthsVerified
Review clocks exclude applicant hold time · planning totals are estimates

Planning steps and estimates; these are not regulator deadlines.

Cyprus Medical Device Registration Process

Step-by-step Ministry of Health registration process. Total estimated timeline: 6-9 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by Ministry of Health. Appoint a EU Authorized Representative.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to Ministry of Health including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

Ministry of Health reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

0 days

In-depth technical assessment of device safety and performance. Ministry of Health may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, Ministry of Health issues Cyprus market authorization certificate.

Summary: The Cyprus medical device registration process through Αρμόδια Αρχή Ιατροτεχνολογικού Εξοπλισμού (CYMDA), Medical Services and Public Health Services, Ministry of Health (Ministry of Health) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Prior approval recognition
FDA 510(k)/PMANo substitute for EU MDR conformity assessment; useful as predicate documentation in the technical file
Key requirements
  • EU Authorized Representative (for non-EU manufacturers)
  • Notification of the medical devices an operator places on or makes available on the Cypriot market to the CYMDA, by sending the CYMDA spreadsheet to cymda@mphs.moh.gov.cy; the duty derives from Decree No. 7 published in Part II of the Third Supplement of the Official Gazette of 5 January 2012 and is restated in the CYMDA notice of 6 November 2025
  • The notification is per economic operator and not per product: the CYMDA states that one economic operator's notification of a device is independent of another economic operator's notification of the same device
  • Importer details — name, registered trade name or trade mark, registered place of business and address — on the device, its packaging or an accompanying document, without covering any of the manufacturer's markings (MDR Annex I §23.2 / IVDR Annex I §20.2)
  • Information for safe and proper use in English and/or Greek, and necessarily also in Greek for products intended for use by non-healthcare professionals (Decree No. 6 under article 59(1)(ζ) of the Basic Requirements Laws 2002 to 2011); the instructions for use must also meet the requirements of Regulations (EU) 2017/745 and 2017/746
  • Distributors must verify a device's conformity and the presence of the importer details before making it available, and must keep storage and transport conditions within the manufacturer's terms
  • EUDAMED actor registration (MDR Art. 31(1) / IVDR Art. 28(1)) and device registration in the UDI database (MDR Arts. 28-29 / IVDR Arts. 25-26), compulsory since 28 May 2026 under Commission Decision (EU) 2025/2371
  • A clinical investigation or performance study requires authorisation from the CYMDA, which is granted where the Cyprus National Bioethics Committee has not issued a negative opinion (MDR Arts. 62 and 63 to 80 with Annex XV; IVDR Arts. 56 to 57 and 59 to 77 with Annexes XII and XIV)
  • In-vitro diagnostic products are registered with the CYMDA on the separate 'Registration for IVD products' form rather than on the medical-device notification spreadsheet
  • Non-compliant devices may attract administrative measures and/or fines under Law 225(I)/2022 on market surveillance
Primary regulator sources

Reviewed 2026-09-16. End-to-end totals remain planning estimates.

Keep researching this market
View the Cyprus resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against Ministry of Health publications · full review 2026-09-16 · row IDs are stable — cite as registration-timeline:cyprus:class-i